NYSE:CLB - Core Laboratories Stock Price, News & Analysis

$38.77
+1.75 (+4.73 %)
(As of 08/16/2019 04:00 PM ET)
Today's Range
$36.61
Now: $38.77
$39.00
50-Day Range
$36.77
MA: $49.37
$54.96
52-Week Range
$36.61
Now: $38.77
$122.11
Volume600,500 shs
Average Volume819,891 shs
Market Capitalization$1.72 billion
P/E Ratio17.00
Dividend Yield5.76%
Beta1.91
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. Read More…

Industry, Sector and Symbol

Industry Oil & gas field services, not elsewhere classified
Sub-IndustryN/A
SectorOils/Energy
CUSIPN/A
Phone31-20-420-3191

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$700.85 million
Cash Flow$2.8528 per share
Book Value$4.34 per share

Profitability

Net Income$79.52 million

Miscellaneous

Employees4,700
Market Cap$1.72 billion
Next Earnings Date10/23/2019 (Estimated)
OptionableOptionable

Receive CLB News and Ratings via Email

Sign-up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter.


Core Laboratories (NYSE:CLB) Frequently Asked Questions

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories declared a quarterly dividend on Friday, July 12th. Investors of record on Monday, July 22nd will be given a dividend of $0.55 per share on Monday, August 12th. This represents a $2.20 annualized dividend and a dividend yield of 5.67%. The ex-dividend date of this dividend is Friday, July 19th. View Core Laboratories' Dividend History.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) issued its quarterly earnings data on Wednesday, July, 24th. The oil and gas company reported $0.46 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.46. The oil and gas company had revenue of $169.04 million for the quarter, compared to analysts' expectations of $173.46 million. Core Laboratories had a net margin of 14.30% and a return on equity of 51.19%. The firm's revenue was down 3.7% compared to the same quarter last year. During the same period last year, the company posted $0.59 earnings per share. View Core Laboratories' Earnings History.

When is Core Laboratories' next earnings date?

Core Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, October 23rd 2019. View Earnings Estimates for Core Laboratories.

What guidance has Core Laboratories issued on next quarter's earnings?

Core Laboratories issued an update on its third quarter earnings guidance on Wednesday, July, 24th. The company provided earnings per share guidance of $0.48-0.52 for the period, compared to the Thomson Reuters consensus estimate of $0.50. The company issued revenue guidance of $171-175 million, compared to the consensus revenue estimate of $179.03 million.

What price target have analysts set for CLB?

15 analysts have issued twelve-month price objectives for Core Laboratories' stock. Their predictions range from $52.00 to $120.00. On average, they expect Core Laboratories' stock price to reach $75.5455 in the next twelve months. This suggests a possible upside of 94.9% from the stock's current price. View Analyst Price Targets for Core Laboratories.

What is the consensus analysts' recommendation for Core Laboratories?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 1 sell rating, 7 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Core Laboratories.

Has Core Laboratories been receiving favorable news coverage?

News coverage about CLB stock has been trending negative recently, InfoTrie reports. The research group identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Core Laboratories earned a media sentiment score of -2.3 on InfoTrie's scale. They also gave media stories about the oil and gas company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Core Laboratories.

Are investors shorting Core Laboratories?

Core Laboratories saw a increase in short interest during the month of July. As of July 31st, there was short interest totalling 3,819,300 shares, an increase of 16.2% from the June 30th total of 3,286,000 shares. Based on an average trading volume of 694,300 shares, the days-to-cover ratio is currently 5.5 days. Currently, 8.8% of the company's shares are short sold. View Core Laboratories' Current Options Chain.

Who are some of Core Laboratories' key competitors?

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Micron Technology (MU), Starbucks (SBUX), Baidu (BIDU), Athabasca Oil (ATH), NIC (EGOV) and Netflix (NFLX).

Who are Core Laboratories' key executives?

Core Laboratories' management team includes the folowing people:
  • Mr. David M. Demshur, CEO & Chairman of Supervisory Board (Age 64)
  • Mr. Lawrence V. Bruno, COO, Pres & Supervisory Director (Age 59)
  • Mr. Christopher Scott Hill, Sr. VP & CFO (Age 49)
  • Mr. Kevin G. Daniels, Chief Accounting Officer, Treasurer & VP (Age 55)
  • Ms. Gwendolyn Y. Schreffler M.B.A., Sr. VP of Corp. Devel. & Investor Relations

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.50%), BlackRock Inc. (7.30%), Earnest Partners LLC (5.20%), Kayne Anderson Rudnick Investment Management LLC (3.53%), Van ECK Associates Corp (2.87%) and JPMorgan Chase & Co. (2.76%). Company insiders that own Core Laboratories stock include Gregory Barry Barnett, Jan Willem Sodderland and Kevin Daniels. View Institutional Ownership Trends for Core Laboratories.

Which institutional investors are selling Core Laboratories stock?

CLB stock was sold by a variety of institutional investors in the last quarter, including Evercore Wealth Management LLC, Envestnet Asset Management Inc., Parametric Portfolio Associates LLC, Northern Trust Corp, Schroder Investment Management Group, Russell Investments Group Ltd., Grandeur Peak Global Advisors LLC and BNP Paribas Arbitrage SA. View Insider Buying and Selling for Core Laboratories.

Which institutional investors are buying Core Laboratories stock?

CLB stock was acquired by a variety of institutional investors in the last quarter, including Van ECK Associates Corp, Manning & Napier Group LLC, Earnest Partners LLC, Granite Investment Partners LLC, Teacher Retirement System of Texas, Marshall Wace North America L.P., Steadfast Capital Management LP and Bell Asset Management Ltd. Company insiders that have bought Core Laboratories stock in the last two years include Gregory Barry Barnett and Jan Willem Sodderland. View Insider Buying and Selling for Core Laboratories.

How do I buy shares of Core Laboratories?

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $38.77.

How big of a company is Core Laboratories?

Core Laboratories has a market capitalization of $1.72 billion and generates $700.85 million in revenue each year. The oil and gas company earns $79.52 million in net income (profit) each year or $2.28 on an earnings per share basis. Core Laboratories employs 4,700 workers across the globe.View Additional Information About Core Laboratories.

What is Core Laboratories' official website?

The official website for Core Laboratories is http://www.corelab.com/.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]


MarketBeat Community Rating for Core Laboratories (NYSE CLB)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  413 (Vote Outperform)
Underperform Votes:  545 (Vote Underperform)
Total Votes:  958
MarketBeat's community ratings are surveys of what our community members think about Core Laboratories and other stocks. Vote "Outperform" if you believe CLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel